These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 32474851)

  • 21. Clarifying the record on hydroxychloroquine for the treatment of patients hospitalized with COVID-19.
    Rosenberg ES; Holtgrave DR; Udo T
    Int J Infect Dis; 2020 Oct; 99():38-39. PubMed ID: 32738483
    [No Abstract]   [Full Text] [Related]  

  • 22. Effectiveness of hydroxychloroquine in COVID-19 disease: A done and dusted deal?
    d'Arminio Monforte A; Tavelli A; Bai F; Marchetti G; Cozzi-Lepri A
    Int J Infect Dis; 2020 Oct; 99():75-76. PubMed ID: 32738491
    [No Abstract]   [Full Text] [Related]  

  • 23. Hydroxychloroquine in COVID-19: Taking care of statistics to take care of patients.
    Brito-Azevedo A
    Int J Infect Dis; 2020 Oct; 99():324. PubMed ID: 32768698
    [No Abstract]   [Full Text] [Related]  

  • 24. Possible synergistic effects of hydroxychloroquine and steroids in COVID-19, time for a nuanced approach. Comment on Arshad et al.
    Wiseman DM
    Int J Infect Dis; 2020 Oct; 99():344-345. PubMed ID: 32768694
    [No Abstract]   [Full Text] [Related]  

  • 25. Update Alert 2: Should Clinicians Use Chloroquine or Hydroxychloroquine Alone or in Combination With Azithromycin for the Prophylaxis or Treatment of COVID-19? Living Practice Points From the American College of Physicians.
    Qaseem A; Yost J; Etxeandia-Ikobaltzeta I; Humphrey LL
    Ann Intern Med; 2020 Sep; 173(5):W88-W89. PubMed ID: 32730105
    [No Abstract]   [Full Text] [Related]  

  • 26. Pharmacist's perspective on HCQ treatment of COVID-19.
    Wang YL; Wang SH; Yang AY
    Kaohsiung J Med Sci; 2020 Aug; 36(8):660. PubMed ID: 32533592
    [No Abstract]   [Full Text] [Related]  

  • 27. Risch Responds to "How to Consider Low Reported Death Rates in COVID-19".
    Risch HA
    Am J Epidemiol; 2020 Nov; 189(11):1230-1231. PubMed ID: 32685962
    [No Abstract]   [Full Text] [Related]  

  • 28. Deploying Randomized Controlled Trials during the COVID-19 Pandemic: Reason and Bayesian Designs.
    Zampieri FG
    Ann Am Thorac Soc; 2020 Aug; 17(8):937-938. PubMed ID: 32735169
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit.
    Bessière F; Roccia H; Delinière A; Charrière R; Chevalier P; Argaud L; Cour M
    JAMA Cardiol; 2020 Sep; 5(9):1067-1069. PubMed ID: 32936266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benefit v. risk when using chloroquine in patients with severe COVID-19 disease.
    Decloedt EH; Reuter H; Allwood B; Parker A; Koegelenberg CFN; Blockman M; Taljaard J
    S Afr Med J; 2020 Apr; 110(5):12903. PubMed ID: 32657706
    [No Abstract]   [Full Text] [Related]  

  • 31. Reply to Gautret et al: hydroxychloroquine sulfate and azithromycin for COVID-19: what is the evidence and what are the risks?
    Machiels JD; Bleeker-Rovers CP; Ter Heine R; Rahamat-Langendoen J; de Mast Q; Ten Oever J; Bousema T; van Crevel R; Wertheim HF
    Int J Antimicrob Agents; 2020 Jul; 56(1):106056. PubMed ID: 32674929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does Combining Severe and Mild Cases of COVID-19 Produce Low Fatality Rates After Treatment With Hydroxychloroquine and Azithromycin?
    Fleury V
    Am J Epidemiol; 2020 Nov; 189(11):1227-1229. PubMed ID: 32685969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
    Gautret P; Lagier JC; Parola P; Hoang VT; Meddeb L; Mailhe M; Doudier B; Courjon J; Giordanengo V; Vieira VE; Tissot Dupont H; Honoré S; Colson P; Chabrière E; La Scola B; Rolain JM; Brouqui P; Raoult D
    Int J Antimicrob Agents; 2020 Jul; 56(1):105949. PubMed ID: 32205204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Good, the Bad, and the Hoax: When Publication Instantaneously Impacts Treatment Strategies for COVID-19.
    Danion F; Ruch Y; Fourtage M; Kaeuffer C; Greigert V; Lefebvre N; Muller J; Nai T; Hansmann Y
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513798
    [No Abstract]   [Full Text] [Related]  

  • 35. An Ounce of Prevention and a Pound of Cure: Randomized Clinical Trials of Therapeutics Against COVID-19 and an Assessment of Personal Protective Equipment and Distancing.
    Sher DJ
    Int J Radiat Oncol Biol Phys; 2020 Oct; 108(2):333-336. PubMed ID: 32890500
    [No Abstract]   [Full Text] [Related]  

  • 36. Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19).
    Mercuro NJ; Yen CF; Shim DJ; Maher TR; McCoy CM; Zimetbaum PJ; Gold HS
    JAMA Cardiol; 2020 Sep; 5(9):1036-1041. PubMed ID: 32936252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RE: "EARLY OUTPATIENT TREATMENT OF SYMPTOMATIC, HIGH-RISK COVID-19 PATIENTS THAT SHOULD BE RAMPED UP IMMEDIATELY AS KEY TO THE PANDEMIC CRISIS".
    Peiffer-Smadja N; Costagliola D
    Am J Epidemiol; 2020 Nov; 189(11):1443-1444. PubMed ID: 32685975
    [No Abstract]   [Full Text] [Related]  

  • 38. QT Interval Control to Prevent Torsades de Pointes during Use of Hydroxychloroquine and/or Azithromycin in Patients with COVID-19.
    Wu TC; Sacilotto L; Darrieux FCDC; Pisani CF; Melo SL; Hachul DT; Scanavacca M
    Arq Bras Cardiol; 2020 Jun; 114(6):1061-1066. PubMed ID: 32638906
    [No Abstract]   [Full Text] [Related]  

  • 39. Hydroxychloroquine and Azithromycin to Treat Patients With COVID-19: Both Friends and Foes?
    Mégarbane B; Scherrmann JM
    J Clin Pharmacol; 2020 Jul; 60(7):808-814. PubMed ID: 32434282
    [No Abstract]   [Full Text] [Related]  

  • 40. Practical implementation of COVID-19 patient flags into an antimicrobial stewardship program's prospective review.
    Stevens RW; Estes L; Rivera C
    Infect Control Hosp Epidemiol; 2020 Sep; 41(9):1108-1110. PubMed ID: 32290883
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.